MRO Cost & Pricing Analysis 3 — Questions and Answers
Question 1: When calculating the total cost of a DOT drug testing program, which recurring operational cost is often underestimated by employers?
- One-time policy development fees
- Ongoing MRO review fees for negative results (Correct answer)
- Annual SAMHSA certification renewals
- Equipment purchase for in-house testing
Correct answer: Ongoing MRO review fees for negative results
Employers often focus on positive-result costs but MRO review fees apply to all specimens, including the majority that test negative.
Question 2: A federally mandated random drug testing program requires 50% annual testing of safety-sensitive employees. Which cost model best allows an employer to accurately budget for this requirement?
- Pay-per-positive model
- Flat annual subscription regardless of volume
- Per-test fee multiplied by projected random selections (Correct answer)
- Charging only when the MRO calls the donor
Correct answer: Per-test fee multiplied by projected random selections
Multiplying the per-test fee by the number of expected random selections (50% of covered employees) provides the most accurate budget projection.
Question 3: An employer switches MROs mid-year. Which cost consideration is most critical during this transition?
- Reimbursing the prior MRO for unsent invoices
- Ensuring all pending reviews and open files are transferred or resolved without additional donor re-testing costs (Correct answer)
- Ordering new chain-of-custody forms
- Notifying SAMHSA of the change
Correct answer: Ensuring all pending reviews and open files are transferred or resolved without additional donor re-testing costs
Unresolved specimens in the prior MRO's queue must be transferred or completed to avoid duplicate collection costs and compliance gaps.
Question 4: Which factor most significantly drives differences in MRO review pricing between providers?
- Geographic location of the MRO's office
- Volume of specimens reviewed and included ancillary services (Correct answer)
- The drug panel size tested
- The collection site network used
Correct answer: Volume of specimens reviewed and included ancillary services
Higher specimen volumes allow MROs to offer lower per-test rates, and bundled ancillary services such as DER notifications affect overall pricing.
Question 5: For DOT-regulated pre-employment testing, the cost of a cancelled test (e.g., due to a fatal flaw on the CCF) is typically borne by:
- The donor, who must pay for recollection
- The MRO, who waives the review fee
- The employer, who must arrange and pay for a recollection (Correct answer)
- The collection site, which is liable for the flaw
Correct answer: The employer, who must arrange and pay for a recollection
When a test is cancelled due to a fatal flaw, the employer must fund a new collection because the cancelled test cannot satisfy the testing requirement.
Question 6: An MRO's contract with an employer specifies a 'per-verified result' fee only for non-negative outcomes. This arrangement is:
- Compliant if disclosed to the employer
- Permissible under 49 CFR Part 40
- Potentially problematic because it incentivizes the MRO to report more non-negative results (Correct answer)
- Required by DOT for cost efficiency
Correct answer: Potentially problematic because it incentivizes the MRO to report more non-negative results
Charging only for non-negative verifications creates a financial incentive that could bias the MRO toward reporting positive or non-negative outcomes.
Question 7: Which entity sets the minimum standards for MRO qualifications, indirectly affecting the cost of qualified MRO services in the market?
- The Department of Labor
- The Department of Transportation (DOT) via 49 CFR Part 40 (Correct answer)
- SAMHSA's National Laboratory Certification Program
- The American College of Occupational and Environmental Medicine
Correct answer: The Department of Transportation (DOT) via 49 CFR Part 40
DOT's 49 CFR Part 40 establishes MRO qualification requirements including licensure and training, which set the floor for qualifying practitioners.
MRO Cost & Pricing Analysis 3
When calculating the total cost of a DOT drug testing program, which recurring operational cost is often underestimated by employers?